New drug offers hope for hormone-resistant prostate cancer
A groundbreaking study has shown that a drug currently being tested for ovarian and bile duct cancer, called NXP800, could also help treat advanced prostate cancer that no longer responds to hormone therapy. Published in Clinical Cancer Research, the study highlights how NXP800 slows the growth of prostate cancer cells, even in cases resistant to standard […]
Breakthrough discovery shows big cause of prostate cancer spread
Breakthrough discovery shows big cause of prostate cancer spread
A new breakthrough in pancreatic cancer treatment
Pancreatic cancer is one of the deadliest forms of cancer, with survival rates remaining alarmingly low.
How obesity increases cancer risk
Regular physical activity may lower cancer development and death risks
New way to treat kidney diseases in older people
Annual health checkups often include urine tests, which are important for monitoring overall health and detecting early signs of kidney disease.
Aspirin does not help prevent colon cancer recurrence
Aspirin does not help prevent colon cancer recurrence
Key enzyme identified as potential target for cancer immunotherapy
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, is strongly induced in CD8+ T cells in solid cancer, the primary immune cells involved in combating cancer. P4HA1 causes disruptions in energy production within the cells, which leads to weaker immune cells that are less able to fight cancer and form long-lasting anti-cancer immunity, highlighting P4HA1 as a promising target for treating solid tumors.
The #1 Cancer-Fighting Food To Eat Because It ‘Slows Tumor Growth’ And Blocks Its Ability To Spread, Health Expert Reveals | SHEfinds
Cancer is a complex disease characterized by the uncontrolled growth of abnormal cells in the body.
BeiGene wins US nod for Tevimbra label expansion (BGNE:NASDAQ) | Seeking Alpha
BeiGene (BGNE) has received U.S. FDA approval for its cancer drug Tevimbra in combination with chemotherapy for certain gastric carcinoma. Read more here.
Press release for research from the 2024 ASTRO Annual Meeting
IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer – American Society for Radiation Oncology (ASTRO)
Zai Lab stock rises on Tivdak trial data (ZLAB:NASDAQ) | Seeking Alpha
Zai Lab (ZLAB) stock rose after positive trial data for its cervical cancer drug Tivdak and its plans to seek marketing approval for the drug in China. Read more here.
